|
|
||||||||
Articles |
Thirteen dogs with histopathologically confirmed malignancies were treated with mitoxantrone and cyclophosphamide combination therapy. One to four doses were administered at 21-day intervals. Recombinant human granulocyte colony-stimulating factor was administered to ameliorate myelosuppression in dogs with neutrophil nadirs less than 1,000/microl. While the protocol appears to be safe for use in tumor-bearing dogs, an advantage over mitoxantrone single-agent protocols in terms of tumor response was not demonstrated in this initial pilot study.
This article has been cited by other articles:
![]() |
J. Lawrence, L. Forrest, W. Adams, D. Vail, and D. Thamm Four-Fraction Radiation Therapy for Macroscopic Soft Tissue Sarcomas in 16 Dogs J. Am. Anim. Hosp. Assoc., May 1, 2008; 44(3): 100 - 108. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |